HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nissar A Darmani Selected Research

bisindolylmaleimide I

1/2021The Contribution of Phospholipase C in Vomiting in the Least Shrew (Cryptotis Parva) Model of Emesis.
1/2021Signal transduction pathways involved in dopamine D2 receptor-evoked emesis in the least shrew (Cryptotis parva).
9/2018Intracellular emetic signaling evoked by the L-type Ca2+ channel agonist FPL64176 in the least shrew (Cryptotis parva).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nissar A Darmani Research Topics

Disease

43Vomiting
01/2022 - 01/2002
11Nausea
05/2021 - 01/2005
7Neoplasms (Cancer)
06/2021 - 01/2005
2Pain (Aches)
09/2007 - 06/2005
1Restless Legs Syndrome (Restless Legs)
11/2020
1Parkinson Disease (Parkinson's Disease)
11/2020
1Nervous System Diseases (Neurological Disorders)
11/2020
1Schizophrenia (Dementia Praecox)
11/2020
1Bacterial Infections (Bacterial Infection)
01/2017

Drug/Important Bio-Agent (IBA)

24AntiemeticsIBA
06/2021 - 01/2002
22EmeticsIBA
06/2021 - 01/2002
20Cisplatin (Platino)FDA LinkGeneric
01/2020 - 01/2003
15Serotonin (5 Hydroxytryptamine)IBA
06/2021 - 03/2004
13Substance PIBA
06/2021 - 09/2005
12CannabinoidsIBA
01/2020 - 01/2002
10Palonosetron (Aloxi)FDA Link
06/2021 - 01/2014
9Dopamine (Intropin)FDA LinkGeneric
06/2021 - 01/2005
8netupitantIBA
06/2021 - 04/2015
8Neurotransmitter Agents (Neurotransmitter)IBA
05/2021 - 09/2005
8RimonabantIBA
12/2019 - 01/2002
7Nifedipine (Adalat)FDA LinkGeneric
06/2021 - 01/2014
65-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
06/2021 - 01/2014
5Dronabinol (THC)FDA LinkGeneric
01/2020 - 01/2002
5GR 73632IBA
12/2019 - 06/2008
5TachykininsIBA
04/2015 - 06/2008
4Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2021 - 01/2013
4Dantrolene (Dantrium)FDA LinkGeneric
01/2021 - 01/2014
4Dopamine Agonists (Dopamine Agonist)IBA
11/2020 - 01/2005
4EndocannabinoidsIBA
01/2014 - 09/2005
3U 0126 (UO 126)IBA
06/2021 - 01/2021
3bisindolylmaleimide IIBA
01/2021 - 09/2018
3QuinpiroleIBA
01/2021 - 01/2005
3CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2019 - 01/2005
33- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA
12/2019 - 01/2003
3Tropisetron (Navoban)IBA
08/2017 - 01/2009
3FPL 64176IBA
01/2017 - 01/2014
3CalciumIBA
01/2017 - 01/2014
3Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
04/2016 - 01/2014
3Amlodipine (Norvasc)FDA LinkGeneric
05/2015 - 01/2014
3ApomorphineFDA Link
05/2014 - 01/2005
3Arachidonic Acid (Vitamin F)IBA
09/2010 - 01/2002
3anandamide (arachidonylethanolamide)IBA
01/2006 - 06/2005
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2013
22- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2021 - 09/2018
2Ion Channels (Ion Channel)IBA
11/2020 - 01/2014
2EnzymesIBA
11/2020 - 09/2005
2resiniferatoxinIBA
01/2020 - 01/2014
25-Hydroxytryptophan (5 Hydroxytryptophan)IBA
12/2019 - 03/2004
2CB2 Cannabinoid ReceptorIBA
12/2019 - 06/2007
22- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
09/2018 - 01/2014
2leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
08/2017 - 02/2010
2pranlukastIBA
08/2017 - 02/2010
2LeukotrienesIBA
08/2017 - 02/2010
2ThapsigarginIBA
01/2017 - 04/2016
2L-Type Calcium Channels (Dihydropyridine Receptor)IBA
05/2015 - 01/2014
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
04/2015 - 01/2014
2Messenger RNA (mRNA)IBA
01/2013 - 01/2010
2ProstaglandinsIBA
09/2010 - 09/2005
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2009 - 09/2005
2Mesylates (Mesylate)IBA
06/2007 - 01/2003
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2007 - 01/2005
2glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
09/2005 - 01/2003
1temsirolimusFDA Link
01/2022
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2021
1N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA
06/2021
1Glycogen Synthase Kinase 3IBA
06/2021
1SB 216763IBA
06/2021
1MK 2206IBA
06/2021
1perifosineIBA
06/2021
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2021
1mu Opioid Receptors (mu Opioid Receptor)IBA
01/2021
1Histamine (Histamine Dihydrochloride)FDA Link
01/2021
1Sulpiride (neogama)IBA
01/2021
12,4,6- trimethyl- N- (meta- 3- trifluoromethylphenyl)benzenesulfonamideIBA
01/2021
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2021
1Protein Kinase CIBA
01/2021
11- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA
01/2021
1Type C PhospholipasesIBA
01/2021
1Dopamine Receptors (Dopamine Receptor)IBA
11/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2020
1LigandsIBA
11/2020
1Copper Sulfate (Sulfate, Copper)FDA Link
01/2020
1Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA
08/2017
1palosentron drug combination netupitantIBA
01/2017
1Cholinergic Agents (Cholinergics)IBA
01/2017
1Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
01/2017
1ProdrugsIBA
04/2016
14- methyl- 4'- (3,5- bis(trifluoromethyl)- 1H- pyrazol- 1- yl)- 1,2,3- thiadiazole- 5- carboxanilideIBA
04/2016
1Inositol (Myoinositol)IBA
04/2016
1RyanodineIBA
04/2016
1Serotonin ReceptorsIBA
04/2016
1Phosphotransferases (Kinase)IBA
04/2015
1Protein Kinases (Protein Kinase)IBA
04/2015
1Protein Kinase C-alphaIBA
04/2015
1(4- (m- Chlorophenylcarbamoyloxy)- 2- butynyl)trimethylammonium ChlorideIBA
05/2014
1Pilocarpine (Ocusert)FDA LinkGeneric
05/2014

Therapy/Procedure

9Drug Therapy (Chemotherapy)
09/2018 - 07/2007
3Therapeutics
01/2021 - 01/2017
2Injections
02/2010 - 06/2009
2Osteopathic Manipulation
09/2007 - 06/2005